National Comprehensive Cancer Network 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.“Lung Cancer Expert Not Buying ASCO Report on Screenings’ Cost,“ City of Hope Comprehensive Cancer Network
New screening guidelines for lung cancer could save thousands of lives—but it won’t come cheap, according to a mathematical model devised to estimate Medicare costs for screening seniors who fit the criteria. The findings add fuel to ongoing debate over lung cancer screening, two weeks after an advisory panel for the U.S. Centers for Medicare and Medicaid Services recommended against coverage for the screening. City of Hope Comprehensive Cancer Center's Dan Raz, MD, co-director of the Lung Cance... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news
“Obesity May Impact Breast Cancer Survival in Younger Women,” CBSNews.com
This article features commentary from a physician from Memorial Sloan Kettering Cancer Center-one of the 25 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news
NCCN Publishes Comprehensive Stage-Specific Breast Cancer Resources for Patients
New NCCN Guidelines for Patients®: Breast Cancer Stages 0 - IV now available free-of-charge at NCCN.org/patients; NCCN Guidelines for Patients® are educational resources that offer patient-friendly treatment information.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of the NCCN Guidelines for Patients®: Breast Cancer Stages 0 - IV-the latest addition to the library of NCCN Guidelines for Patie... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 7, 2014 Category: Cancer & Oncology Source Type: news
“Cancer and the Goldilocks Effect,” UC San Diego Moores Cancer Center
Researchers at the University of California, San Diego School of Medicine have found that too little or too much of an enzyme called SRPK1 promotes cancer by disrupting a regulatory event critical for many fundamental cellular processes, including proliferation. UC San Diego Moores Cancer Center is one of the 25 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 5, 2014 Category: Cancer & Oncology Source Type: news
NCCN Holds Third Annual State Oncology Society Forum
The third annual NCCN State Oncology Society Forum, held at the NCCN 19th Annual Conference, examining the evaluation of quality in oncology, the utilization of clinical guidelines and pathways, and the consequences with the Sunshine Act.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) held its third annual State Oncology Society Forum during the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™, facilitating discussions of quality evaluation and... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 4, 2014 Category: Cancer & Oncology Source Type: news
“Tumor Suppressor Gene TP53 Mutated in 90 Percent of Most Common Childhood Bone Tumor,” St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project found mutations in the tumor suppressor gene TP53 in 90 percent of osteosarcomas, suggesting the alteration plays a key role early in development of the bone cancer. The research was published Thursday online ahead of print in the journal Cell Reports. Authors from this story also represent The University of Texas MD Anderson Cancer Center and Siteman Cancer Center at Barnes-Jewish Hospital and Washin... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 3, 2014 Category: Cancer & Oncology Source Type: news
“Jamming a Protein Signal Forces Cancer Cells to Devour Themselves,” The University of Texas MD Anderson Cancer Center
Interfering with a single cancer-promoting protein and its receptor can turn this resistance mechanism into lethal, runaway self-cannibalization, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cell Reports.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 3, 2014 Category: Cancer & Oncology Source Type: news
NCCN Receives $2.2 Million in Research Funding from Astellas and Medivation to Study Enzalutamide in Solid Tumors
The NCCN Oncology Research Program (ORP) received a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to facilitate studies of enzalutamide in bladder, breast, endometrial, hepatocellular, ovarian, and prostate cancers.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has been awarded a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to develop a program to scientifically evaluate and define the cl... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 3, 2014 Category: Cancer & Oncology Source Type: news
“Lack of Insurance Coverage a Barrier to Lung Cancer Screening,” Roswell Park Cancer Institute
The majority of current and former smokers would welcome screenings for lung cancer if their insurance covered the spiral computed tomography (CT) scans, according to research from Roswell Park Cancer Institute and the Medical University of South Carolina and published online ahead of print in the journal Lung Cancer. Roswell Park Cancer Institute is one of the 25 NCCN Member Institutions.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 2, 2014 Category: Cancer & Oncology Source Type: news
“Likely Culprit in Spread of Colon Cancer Identified,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
New research at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine and Vanderbilt-Ingram Cancer Center-both NCCN Member Institutions-has implicated a poorly understood protein called PLAC8 in the spread of colon cancer.
... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 1, 2014 Category: Cancer & Oncology Source Type: news
NCCN to Host Policy Summit Concerning Biomarkers and Targeted Therapies in Clinical Trial Design
The National Comprehensive Cancer Network® (NCCN®) will host Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies on April 25, 2014 in Bethesda, Maryland, as part of the NCCN Oncology Policy Program.
FORT WASHINGTON, PA - On April 25, 2014, the National Comprehensive Cancer Network® (NCCN®) will host the NCCN Oncology Policy Summit titled, Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies, at the Bethesda Marriott in Bethesda,... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 29, 2014 Category: Cancer & Oncology Source Type: news
NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Nintedanib* in Colorectal and Lung Cancers
The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of nintedanib in colorectal and lung cancers at NCCN Member Institutions.
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has been awarded a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to scientifically evaluate and define the safety and clinical effectiv... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 25, 2014 Category: Cancer & Oncology Source Type: news
NCCN Roundtable Considers the Effect of Health Care Reform on Oncology Practice: Confronting Risk
The second roundtable of the NCCN 19th Annual Conference explored the Affordable Care Act (ACA) and the new-found risk that providers, payers, and patients are learning to navigate.
FORT WASHINGTON, PA- On Friday, March 14, 2014, the National Comprehensive Cancer Network® (NCCN®) hosted its second roundtable of the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™, titled, The Affordable Care Act: Where are We Now? Clifford Goodman, PhD, The Lewin Group, moderated the ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 21, 2014 Category: Cancer & Oncology Source Type: news
Nccn 19
NCCN's opening roundtable focused on the child's experience when a parent has cancer, noting that honest, age-appropriate communication about cancer, its treatment, and death are beneficial at any age.
FORT WASHINGTON, PA - On March 13, 2014, The National Comprehensive Cancer Network® (NCCN®) opened its 19th Annual Conference: Advancing the Standard of Cancer Care™ with a roundtable discussion titled, The Child's Experience When a Parent has Cancer. The panel, moderated by Lil... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 20, 2014 Category: Cancer & Oncology Source Type: news
Highlights from NCCN 19
More than 1,300 oncology representatives attended the NCCN 19th Annual Conference, which featured presentations of the latest developments in the treatment of more than 15 cancer types, as well as two expert roundtable discussions.
FORT WASHINGTON, PA - The NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ was hosted by the National Comprehensive Cancer Network® (NCCN®) from March 13 - 15, 2014 at the Westin Diplomat in Hollywood, Florida. The latest updates in clinical ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 19, 2014 Category: Cancer & Oncology Source Type: news
